Activation of ERK and SAPK cascades (subgroups of the mitogen- activated protein kinases, MAPK) culminates in opposing cellular phenotypes. ERKs (extracellular signal-regulated kinase) function as mediators of growth factor- or phorbol ester-induced cellular proliferation; whereas, SAPKs (stress-activated protein kinase) are involved in regulation of cytokine-induced cellular differentiation, apoptosis or growth arrest. Although small molecular weight GYP-binding proteins have been shown to be a common element upstream from both ERK (ras) and SAPK (rac), the understanding of the physiologically relevant second messengers that control or provide specificity for these discrete signaling pathways is not dear. Sphingolipid metabolites have been shown to influence kinases and phosphatases both in intact cell and cell- free systems. Sphingolipid-derivatives also regulate receptor autophosphorylation and receptor-linked small molecular weight GYP- binding proteins. Sphingomyelin, the major membrane sphingolipid 1 can be hydrolyzed to form ceramide and then deacylated to generate sphingosine. Inflammatory cytokine-induced cellular differentiation or apoptosis has been linked to ceramide generation; whereas, growth factor-mediated Cell proliferation has been associated with sphingosine formation. The role of ceramide and sphingosine to differentially regulate ERK and SAPK cascades and to determine. in part, the cellular phenotype has been therefore hypothesized. It is specifically hypothesized that growth factor receptor-induced proliferation may be mediated by sphingosine-regulated ERK bioactivity while cytokine receptors may signal an inflammatory response and/or growth arrest through a ceramide-regulated SAPK cascade. The role of sphingolipid metabolites to differentially regulate ERK and SAPK cascades will be investigated at three levels in rat glomerular mesangial cells: 1) as cofactors for specific kinases or phosphatases; 2) as regulators for small molecular weight GYP-binding proteins; 3) as modulators of receptor/ligand binding kinetics. These studies will establish sphingomyelin derived second messengers as key mediators of cellular proliferation and differentiation via activation of discrete protein kinase cascades.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK053715-03
Application #
2900341
Study Section
Human Embryology and Development Subcommittee 1 (HED)
Program Officer
Sato, Sheryl M
Project Start
1997-08-01
Project End
2001-03-31
Budget Start
1999-04-01
Budget End
2000-03-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Pennsylvania State University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
129348186
City
Hershey
State
PA
Country
United States
Zip Code
17033
Kester, Mark; Kolesnick, Richard (2003) Sphingolipids as therapeutics. Pharmacol Res 47:365-71
Yun, Jong K; Kester, Mark (2002) Regulatory role of sphingomyelin metabolites in hypoxia-induced vascular smooth muscle cell proliferation. Arch Biochem Biophys 408:78-86
Bourbon, Nicole A; Sandirasegarane, Lakshman; Kester, Mark (2002) Ceramide-induced inhibition of Akt is mediated through protein kinase Czeta: implications for growth arrest. J Biol Chem 277:3286-92
Kester, M; Waybill, P; Kozak, M (2001) New strategies to prevent restenosis. Am J Cardiovasc Drugs 1:77-83
Sandirasegarane, L; Kester, M (2001) Enhanced stimulation of Akt-3/protein kinase B-gamma in human aortic smooth muscle cells. Biochem Biophys Res Commun 283:158-63
Edwards, L; Fishman, D; Horowitz, P et al. (2001) The I1-imidazoline receptor in PC12 pheochromocytoma cells activates protein kinases C, extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK). J Neurochem 79:931-40
Bourbon, N A; Yun, J; Berkey, D et al. (2001) Inhibitory actions of ceramide upon PKC-epsilon/ERK interactions. Am J Physiol Cell Physiol 280:C1403-11
Charles, R; Sandirasegarane, L; Yun, J et al. (2000) Ceramide-coated balloon catheters limit neointimal hyperplasia after stretch injury in carotid arteries. Circ Res 87:282-8
Bourbon, N A; Yun, J; Kester, M (2000) Ceramide directly activates protein kinase C zeta to regulate a stress-activated protein kinase signaling complex. J Biol Chem 275:35617-23
Sandirasegarane, L; Charles, R; Bourbon, N et al. (2000) NO regulates PDGF-induced activation of PKB but not ERK in A7r5 cells: implications for vascular growth arrest. Am J Physiol Cell Physiol 279:C225-35